Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
things
heating up a bit here, may have another run in this one.
best
who
not
in love with that proxy vote thing. On face appears massive compensation for management and shaft city for shareholders.
will hold here see how things play out, still feel like there is a decent turnaround here later in the year
best
who
nice week
looking better here now.
best
who
Synchrony to Offer CareCredit Financial Services to Orthopedic Patients
March 22 2022 - 08:00AM
GlobeNewswire Inc.
Alert
Print
Share On Facebook
Conformis, Inc. (NASDAQ: CFMS), the pioneer and leader of fully personalized knee and hip replacement systems, today announced a strategic marketing partnership with Synchrony (NYSE: SYF) that will add the innovative Image-to-Implant® Platinum Services? Program to Synchrony’s successful CareCredit offering. The CareCredit credit card is accepted at more than 250,000 providers and health-focused retail locations, including 20 health systems, and has more than 11 million cardholder accounts.
CareCredit and Conformis will promote the availability of the CareCredit program to orthopedic surgeons and medical facilities across the United States. The strategic partnership is designed to provide an easy-to-use financing option for health facilities to offer to patients to help pay out-of-pocket costs related to knee replacement using Conformis systems, including personalization service upgrades under Conformis’ recently announced Platinum Services Program.
“Increasingly, patients undergoing orthopedic care, such as joint replacement, are choosing upgraded services that can result in out-of-pocket costs to the patient,” said Mark Augusti, Chief Executive Officer and President of Conformis. “We are excited about our marketing collaboration with Synchrony, which will allow medical facilities to offer CareCredit‘s convenient payment options to patients for these costs.”
The new marketing partnership will be highlighted during the 2022 American Academy of Orthopaedic Surgeons (AAOS) Annual Meeting March 22-26, 2022, in Chicago, IL at the Conformis Product Booth #1867 and at the CareCredit Booth #805.
When patients seeking orthopedic services have an out-of-pocket investment, cost can often be a concern and barrier to treatment. With the CareCredit credit card, orthopedic practices can help patients overcome this challenge and move forward with the recommended procedure and get the required implants or other therapeutic products they may need. CareCredit can also be used to pay for care not covered by insurance, including elective procedures, copays, deductibles and coinsurance.
“Providing financial solutions that can help increase access to healthcare services like orthopedics is imperative – especially in today’s economic environment,” said Claude Royster, Vice President, General Manager – CareCredit. “At CareCredit, we’re very pleased to join with Conformis in this effort because we share a common goal to do what we can to support the health and wellness of orthopedic patients, as well as the Doctors of Orthopedic Medicine and their practices.”
This partnership comes as more patients are interested in personalized medicine and have indicated a strong preference for fully personalized implants, as supported by a new clinical study published in The Journal of Bone & Joint Surgery Reviews (JBJS Reviews). The research found that bilateral knee patients prefer Conformis’ fully personalized solution over competitive off-the-shelf implants by a factor of more than 10 to 1.
Orthopedic practices accepting the CareCredit credit card who would like additional tools and resources to promote special financing should call 800.859.9975 or visit https://www.carecredit.com/providercenter/medical-specialties/. Practices not currently accepting CareCredit but who are interested in maximizing treatment acceptance should call 800.300.3046 or visit https://www.carecredit.com/providercenter/medical-specialties/ to learn more or enroll.
About Conformis, Inc.
Conformis is a medical technology company focused on advancing orthopedic patient care and creating a world without joint pain. Its product portfolio is designed to maximize surgeon and patient choice by offering fully personalized solutions through its Image-to-Implant® Platinum Services? Program as well as data-informed, standardized solutions that combine many benefits of personalization with the convenience and flexibility of an off-the-shelf system. Conformis’ sterile, just-in-time, Surgery-in-a-Box™ delivery system is available with all of its implants and personalized, single-use instruments. Conformis owns or exclusively in-licenses issued patents and pending patent applications that cover personalized implants and patient-specific instrumentation for all major joints.
For more information, visit www.conformis.com. To receive future press releases via e-mail alerts, sign up at ir.conformis.com.
About CareCredit
CareCredit, a Synchrony solution, is a leading provider of promotional financing to consumers for health, veterinary and personal care procedures, services and products. For more than 30 years, CareCredit has helped millions of people by offering special financing options with convenient monthly payments.
About Synchrony
Synchrony (NYSE: SYF) is a premier consumer financial services company delivering customized financing programs across key industries including retail, health, auto, travel and home, along with award-winning consumer banking products. With more than $140 billion in sales financed and 80.3 million active accounts, Synchrony brings deep industry expertise, actionable data insights, innovative solutions and differentiated digital experiences to improve the success of every business we serve and the quality of each life we touch. More information can be found at www.synchrony.com and through Twitter: @Synchrony.
glta
Follow Board
Keyboard Shortcuts
Report TOS Violation
© Copyright 2022
About Us
Terms of Service
Privacy Policy
nice thank you
we made it traded over our 50 day all afternoon and closed strong.
Maybe we can start to turn this ship around.
best
who
CFMS .6734 Good morning Who there is some good stuff,alot of reading,looking now,they do have alot of cash, restructered debt
https://www.sfgate.com/business/article/ConforMIS-Q4-Earnings-Snapshot-16972423.php
Including results for cfms institutional buying.
Do you want results only for cfms intitutional buying?
Vanguard Institutional | Experienced Industry Experts
https://institutional.vanguard.com/vanguard/institutional
AdDiscover The Vanguard Difference: See How We Put Our Clients First. See How You Can Benefit From More Than 40 Years Of Asset Management Experience.
Bank of America - Investment Solutions
https://business.bofa.com/marketinsights
AdGet Trusted Advice and Execution Strategies to Help Achieve Your Strategic Goals.
Institutional Asset Management | and Investment Solutions
Adhttps://www.capitalgroup.com/institutional/investment
Conformis (NASDAQ:CFMS) Institutional Buying and Selling
Reporting Date
Hedge Fund
Shares Held
Market Value
Ownership in Company
2/23/2022 BlackRock Inc. 2,963,987 $2.26M 1.593%
2/16/2022 Wasatch Advisors Inc. 18,252,244 $13.90M 9.808%
2/15/2022 Stonepine Capital Management LLC 14,768,823 $11.25M 7.936%
2/15/2022 Millennium Management LLC 214,078 $0.16M 0.115%
24 more rows ...
Feb 24 2022
Phone: (844) 978-6257
Email: contact@marketbeat.com
Conformis Institutional Ownership and Major Shareholders ...
www.marketbeat.com/stocks/NASDAQ/CFMS/institutional-ownership/
Was this helpful?
People also ask
Where can I buy CFMS shares?
What happened to the CFMS IPO?
Will CFMS outperform or underperform the S&P 500 over the long term?
How much of conformis's stock is owned by institutions?
Feedback
Conformis Institutional Ownership and Major Shareholders ...
https://www.marketbeat.com/stocks/NASDAQ/CFMS/institutional-ownership
102 rows · Feb 23, 2022 · Of the 56 institutional investors that purchased Conformis stock in the last 24 months, the ...
Email: contact@marketbeat.com
Phone: (844) 978-6257
REPORTING DATE HEDGE FUND SHARES HELD MARKET VALUE
2/23/2022 BlackRock Inc. 2,963,987 $2.26M
2/16/2022 Wasatch Advisors Inc. 18,252,244 $13.90M
2/15/2022 Stonepine Capital Management LLC 14,768,823 $11.25M
2/15/2022 Millennium Management LLC 214,078 $0.16M
I am holding and adding on dips, I see this in the dollars in time.Lets see what happens today
Good luck and have a whopper of a day (:
glta
yup
after the bell fins not too great at all, but pretty sure that is all factored in at this point. Had to get the elective surgeries going again that's all. Not into all the mm conspiracy theories I see from board to board, but man we just keep getting slugged upside the noggin around .68 for a week straight.
be surprised if this isn't quite a bit higher 4-6 months down the road, we'll see.
best
who
CFMS .6742 Looking better imo
https://www.odtmag.com/contents/view_breaking-news/2022-03-02/conformis-suspends-product-delivery-to-russia/#:~:text=Conformis%20is%20suspending%20all%20distribution%20operations%20to%20Russia,distribution%20agreement%20for%20its%20devices%20in%20the%20country.
https://www.barchart.com/stocks/quotes/CFMS/technical-chart?plot=CANDLE&volume=total&data=DO&density=X&pricesOn=1&asPctChange=0&logscale=1&indicators=BBANDS(20,2);SMA(13);PTP(50);SRSI(14,14);WILLR(14,40);ADX(14);ACCUM;MACD(12,26,9);RSI(14,100);SMA(50)&sym=CFMS&grid=1&height=500&studyheight=100
glta
see
we attacked the 50 day moving avg again today only to get beaten back down. That's the 3rd day in the last week, get right up to .68 and they throw a can of whoopazz on us.
oh well, we'll get it
best
who
Good afternoon Who, i hear ya, everything beat down.this one has no excuse imo,no pr,s no updates.they need a new ceo imo.great company with piss poor management imo
i am holding.2nd time around,i cant see it going much lower.Who knows maybe they will let some news out,Covid does not help anything either.
glty
loaded
.57, now I'm done; what a catastrophe this whole market I'm just turning it all off for a few months as far as the stock market goes.
best to us down the road
who
CFMS I think We start heading north soon,so over sold imo
https://www.barchart.com/stocks/quotes/CFMS/technical-chart?plot=CANDLE&volume=total&data=DO&density=X&pricesOn=1&asPctChange=0&logscale=1&indicators=BBANDS(20,2);SMA(13);PTP(50);SRSI(14,14);WILLR(14,40);ADX(14);ACCUM;MACD(12,26,9);RSI(14,100);SMA(50)&sym=CFMS&grid=1&height=500&studyheight=100
GL Who
glta
added
some .67
best
who
CFMS .703 added a few more.
https://www.barchart.com/stocks/quotes/CFMS/technical-chart?plot=CANDLE&volume=total&data=DO&density=X&pricesOn=1&asPctChange=0&logscale=1&indicators=BBANDS(20,2);SMA(13);PTP(50);SRSI(14,14);WILLR(14,40);ADX(14);ACCUM;MACD(12,26,9);RSI(14,100);SMA(50)&sym=CFMS&grid=1&height=500&studyheight=100
glta
I am back in again (:
good luck
to you also, thank you.
still looking probably 6 months or so out from here, just sleeping on this one for a while. Got my shares may pick away a little under .70 still.
we've got the product and the backlog, the covid cold will blow off soon enough.
best
who
watching for entry
glty
doubled down
at .71, avg cost now 80. I'll give it 6 months here.
goes to .60 I'll double again
best
who
THANK YOU Conformis Inc (CFMS)
0.8602 ? 0.0078 (0.92%)
Volume: 890,067 @12/08/21 7:23:21 PM EST
Bid Ask Day's Range
0.89 0.915 0.852 - 0.915
CFMS Detailed Quote
back in here
figure it will take a few months from here to get all those elective surgeries rolling, but this will go again.
best
who
little cool but sleigh is packed
re;
CFMS .98 Now headed to the North Pole Happy Thanksgiving!
https://www.barchart.com/stocks/quotes/CFMS/technical-chart?plot=CANDLE&volume=total&data=DO&density=X&pricesOn=1&asPctChange=0&logscale=1&indicators=BBANDS(20,2);SMA(13);PTP(50);SRSI(14,14);WILLR(14,40);ADX(14);ACCUM;MACD(12,26,9);RSI(14,100);SMA(50)&sym=CFMS&grid=1&height=500&studyheight=100
glta
CFMS .98 Now headed to the North Pole Happy Thanksgiving!
https://www.barchart.com/stocks/quotes/CFMS/technical-chart?plot=CANDLE&volume=total&data=DO&density=X&pricesOn=1&asPctChange=0&logscale=1&indicators=BBANDS(20,2);SMA(13);PTP(50);SRSI(14,14);WILLR(14,40);ADX(14);ACCUM;MACD(12,26,9);RSI(14,100);SMA(50)&sym=CFMS&grid=1&height=500&studyheight=100
glta
CFMS .9589 This is a better direction (:
glta
do'ins good, back from sin city
Conformis Inc (CFMS)
0.9529 ? 0.0267 (2.88%)
Volume: 391,347 @11/24/21 12:10:56 PM EST
Bid Ask Day's Range
0.9529 0.9569 0.92 - 0.96
CFMS Detailed Quote
Conformis Inc (CFMS)
1.015 ? -0.025 (-2.40%)
Volume: 1,751,366 @11/16/21 1:16:31 PM EST
Bid Ask Day's Range
1.01 1.02 1.0 - 1.08
CFMS Detailed Quote
CFMS $1.10 Rsi 31 I am adding, this is a bargain imo.
https://www.barchart.com/stocks/quotes/CFMS/technical-chart?plot=CANDLE&volume=total&data=DO&density=X&pricesOn=1&asPctChange=0&logscale=1&indicators=BBANDS(20,2);SMA(13);PTP(50);SRSI(14,14);WILLR(14,40);ADX(14);ACCUM;MACD(12,26,9);RSI(14,100);SMA(50)&sym=CFMS&grid=1&height=500&studyheight=100
glta
CFMS $1.18 Good article and read imo
https://www.nasdaq.com/articles/conformis-cfms-to-post-q3-earnings%3A-whats-in-the-offing-2021-10-26
glta
CFMS $1.30 I hope We are going to set a way-point due North.Added a few more at 1.21 I hope We stay above this price for good.
https://www.barchart.com/stocks/quotes/CFMS/technical-chart?plot=CANDLE&volume=total&data=DO&density=X&pricesOn=1&asPctChange=0&logscale=1&indicators=BBANDS(20,2);SMA(13);PTP(50);SRSI(14,14);WILLR(14,40);ADX(14);ACCUM;MACD(12,26,9);RSI(14,100);SMA(50)&sym=CFMS&grid=1&height=500&studyheight=100
glta
CFMS $1.27 Going in for a few more today rsi 38 over-sold imo
https://stockcharts.com/h-sc/ui?s=cfms
glta
CFMS $1.33 RSI 40 w/ Double Bottom,Looking good imo
https://www.barchart.com/stocks/quotes/CFMS/technical-chart?plot=CANDLE&volume=total&data=DO&density=X&pricesOn=1&asPctChange=0&logscale=1&indicators=BBANDS(20,2);SMA(13);PTP(50);SRSI(14,14);WILLR(14,40);ADX(14);ACCUM;MACD(12,26,9);RSI(14,100);SMA(50)&sym=CFMS&grid=1&height=500&studyheight=100
glta
tough call
we know the company has the goods, and backlog but it's been pushed out at least 3 months and perhaps 6 based on covid.
just watching on this end for now
best
who
CFMS $1.36 Getting a few more today.I cant pass these bargain prices
glta
CFMS $1.495 Off by only a few mil.Perfect time now for adding.We should flounder around here for a few days and then head for 2 bucks imo
glta
knocked back
by the covid stuff again, bunch of elective surgery put on the back burner.
We'll rip when we get to the backside of this but it seems to have been pushed out 6 months or so; hold everything else constant covid hammers our revenues temporarily.
best
who
CFMS $1.83 We break Thru 1.99 top resistance and We are off to 2 bucks imo
Knee in a Box https://www.conformis.com/surgeon-resource-center/products/knees/
https://www.barchart.com/stocks/quotes/CFMS/technical-chart?plot=CANDLE&volume=total&data=DO&density=X&pricesOn=1&asPctChange=0&logscale=1&indicators=BBANDS(20,2);SMA(13);PTP(50);SRSI(14,14);WILLR(14,40);ADX(14);ACCUM;MACD(12,26,9);RSI(14,100);SMA(50)&sym=CFMS&grid=1&height=500&studyheight=100
glta
we're getting there
2 in clear sight now, little at a time.
best
who
CFMS $1.75 (: On Our Way to $5 imo
https://www.barchart.com/stocks/quotes/CFMS/technical-chart?plot=CANDLE&volume=total&data=WO&density=X&pricesOn=1&asPctChange=0&logscale=1&indicators=BBANDS(20,2);SMA(13);PTP(50);SRSI(14,14);WILLR(14,40);ADX(14);ACCUM;MACD(12,26,9);RSI(14,100);SMA(50)&sym=CFMS&grid=1&height=500&studyheight=100
glta
that's the way
to start a trading week.
best,
who
CFMS $1.65 headed for 2 Bucks and then to Five imo Holding this one Long term and see what Happens.I like it,Huge Growth imo.
glta
holding well
maybe we get a little move to 2
best
who
CFMS $1.50 Headed towards 5 Bucks imo Institutions Love it.Load the Boat imo
8/16/2021 Cubist Systematic Strategies LLC 83,002 $95K 0.0% N/A 0.045%
8/16/2021 State Street Corp 7,080,625 $8.14M 0.0% +13,615.0% 3.808%
8/16/2021 Goldman Sachs Group Inc. 150,759 $0.17M 0.0% +54.2% 0.081%
8/13/2021 Renaissance Technologies LLC 5,698,488 $6.55M 0.0% +4.3% 3.064%
8/13/2021 Gabelli Funds LLC 231,429 $0.27M 0.0% +37.9% 0.124%
8/13/2021 Geode Capital Management LLC 1,620,554 $1.86M 0.0% +7.9% 0.871%
8/13/2021 Vanguard Group Inc. 8,191,728 $9.42M 0.0% +10.6% 4.405%
https://www.barchart.com/stocks/quotes/CFMS/technical-chart?plot=CANDLE&volume=total&data=WO&density=X&pricesOn=1&asPctChange=0&logscale=1&indicators=BBANDS(20,2);SMA(13);PTP(50);SRSI(14,14);WILLR(14,40);ADX(14);ACCUM;MACD(12,26,9);RSI(14,100);SMA(50)&sym=CFMS&grid=1&height=500&studyheight=100
CFMS appears getting ready to make a move.
Even though the Dailies are still negative, the Weekly has been in an uptrend for 11 weeks!
That is because price/volume dynamic has been positive enough to keep the Weeklies in an upturn. But it is a thin edge ahead.
Hopefully both will be positive in harmony to let share price move up soon.
We shall see.
Cheers & GLTA
CFMS $1.38 Auto Pilot set,Headed for 2 Bucks imo
https://www.barchart.com/stocks/quotes/CFMS/technical-chart?plot=CANDLE&volume=total&data=WO&density=X&pricesOn=1&asPctChange=0&logscale=1&indicators=BBANDS(20,2);SMA(13);PTP(50);SRSI(14,14);WILLR(14,40);ADX(14);ACCUM;MACD(12,26,9);RSI(14,100);SMA(50)&sym=CFMS&grid=1&height=500&studyheight=100
glta
Followers
|
16
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
373
|
Created
|
07/02/15
|
Type
|
Free
|
Moderators |
About ConforMIS, Inc.
"ConforMIS is a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants that are individually sized and shaped, or customized, to fit each patient's unique anatomy. ConforMIS offers a broad line of customized knee implants and pre-sterilized, single-use instruments delivered in a single package to the hospital. In recent clinical studies, ConforMIS iTotal CR demonstrated superior clinical outcomes, including better function and greater patient satisfaction, compared to traditional, off-the-shelf implants. ConforMIS owns or exclusively in-licenses approximately 500 issued patents and pending patent applications that cover customized implants and patient-specific instrumentation for all major joints.
For more information, visit www.conformis.com. To receive future releases in e-mail alerts, sign up at http://ir.conformis.com/."
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |